Tropoelastin

Tropoelastin is the **soluble precursor to elastin**, a major structural protein essential for the extensibility and resilience of tissues such as skin, arteries, lungs, and other organs that require elastic recoil[1][2][5]. Encoded by the ELN gene, tropoelastin is synthesized primarily during fetal development and early childhood, after which it assembles into elastic fibers by cross-linking with microfibrillar components in the extracellular matrix[5]. Structurally, **tropoelastin is highly flexible and intrinsically disordered**, with alternating hydrophobic and cross-linking hydrophilic domains, especially rich in glycine, valine, proline, lysine, and alanine residues[4][5]. Upon self-assembly and cross-linking, tropoelastin builds the biological elastomer elastin, endowing tissues with high compliance and durability for repetitive stretching and recoiling[1][2][5]. Tropoelastin also **promotes cell attachment and migration** and is implicated in extracellular matrix signaling and tissue regeneration[3]. Abnormalities in the ELN gene or tropoelastin processing and assembly cause a range of elastin-related pathologies, including vascular anomalies, pulmonary disorders, and connective tissue diseases[5]. There are currently no direct drug therapies targeting tropoelastin, but its central role in tissue mechanics makes it a focus for biomaterials and regenerative medicine applications[5][3].

Other names

Soluble elastin precursorPre-elastin

Not directly targeted pharmacologically; theoretical mechanisms include promoting assembly or cross-linking for tissue engineering, or inhibiting degradation by elastase